摘要: The leukocyte aggregation test (LAT) detects the in vitro adhesion of sensitized, but not nonimmune, recipient leukocytes onto donor kidney cell monolayers. specifically cell-mediated homograft immunity up to 15 days prior appearance clinical signs or alteration chemical indexes. presence a positive reaction always signified incipient rejection, which was usually controlled by intravenously administered, high-dose methylprednisolone sodium succinate (Solu-Medrol) therapy. There no instance treatment effectively reversed rejection negative test. One common form may be characterized LAT results, cellular infiltrate on renal biopsy specimen, and sensitivity